Ronglin Xie

1.3k total citations
31 papers, 1.0k citations indexed

About

Ronglin Xie is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ronglin Xie has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Ronglin Xie's work include Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers) and CAR-T cell therapy research (4 papers). Ronglin Xie is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers) and CAR-T cell therapy research (4 papers). Ronglin Xie collaborates with scholars based in United States, China and Chile. Ronglin Xie's co-authors include Janet L. Stein, André J. van Wijnen, George L. Long, Jane B. Lian, Gary S. Stein, Sayyed K. Zaidi, Amjad Javed, Stephen N. Jones, Martı́n Montecino and Mohammad Q. Hassan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ronglin Xie

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronglin Xie United States 18 754 264 183 108 101 31 1.0k
Euan W. Baxter United Kingdom 14 507 0.7× 226 0.9× 120 0.7× 164 1.5× 62 0.6× 19 741
John Sipley United States 9 382 0.5× 236 0.9× 406 2.2× 63 0.6× 68 0.7× 16 827
Damiano Fantini United States 17 871 1.2× 275 1.0× 173 0.9× 91 0.8× 64 0.6× 27 1.2k
G N van Muijen Netherlands 13 472 0.6× 263 1.0× 267 1.5× 206 1.9× 54 0.5× 13 928
Yao-Yun Liang United States 17 1.2k 1.6× 345 1.3× 236 1.3× 106 1.0× 145 1.4× 20 1.5k
Lenka Kubiczková Czechia 11 479 0.6× 217 0.8× 159 0.9× 107 1.0× 35 0.3× 17 782
Hideo Maki Japan 10 476 0.6× 182 0.7× 196 1.1× 51 0.5× 74 0.7× 15 789
Ninib Baryawno Sweden 16 586 0.8× 292 1.1× 259 1.4× 213 2.0× 71 0.7× 35 1.1k
Mumtaz V. Rojiani United States 14 537 0.7× 169 0.6× 281 1.5× 121 1.1× 57 0.6× 29 931
G W Krissansen New Zealand 16 473 0.6× 202 0.8× 192 1.0× 403 3.7× 84 0.8× 28 1.1k

Countries citing papers authored by Ronglin Xie

Since Specialization
Citations

This map shows the geographic impact of Ronglin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronglin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronglin Xie more than expected).

Fields of papers citing papers by Ronglin Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronglin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronglin Xie. The network helps show where Ronglin Xie may publish in the future.

Co-authorship network of co-authors of Ronglin Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Ronglin Xie. A scholar is included among the top collaborators of Ronglin Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronglin Xie. Ronglin Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiaojiao, et al.. (2025). Macrophage extracellular traps promote peritoneal fibrosis through the ROS/TGF-β/Smad pathway under high-glucose dialysis conditions. International Immunopharmacology. 167. 115748–115748.
3.
Zhi, Cheng, Qiuling Ma, Lin Shi, et al.. (2018). In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia. Molecular Therapy. 26(4). 976–985. 62 indexed citations
4.
Liu, Yarong, Bo Zhu, Qingzhu Jia, et al.. (2018). Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.. Journal of Clinical Oncology. 36(15_suppl). 3045–3045. 1 indexed citations
5.
Ghule, Prachi N., Ronglin Xie, Jaime A. Rivera‐Pérez, et al.. (2016). Maternal expression and early induction of histone gene transcription factor Hinfp sustains development in pre-implantation embryos. Developmental Biology. 419(2). 311–320. 13 indexed citations
6.
Xie, Ronglin, Ricardo Medina, Ying Zhang, et al.. (2009). The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles. Proceedings of the National Academy of Sciences. 106(30). 12359–12364. 30 indexed citations
7.
Xie, Ronglin, Dana Frederick, Sayyed K. Zaidi, et al.. (2009). Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation. Human Molecular Genetics. 19(6). 1048–1057. 30 indexed citations
8.
Lou, Yang, Amjad Javed, Sadiq Hussain, et al.. (2008). A Runx2 threshold for the cleidocranial dysplasia phenotype. Human Molecular Genetics. 18(3). 556–568. 79 indexed citations
9.
Zhang, Ying, Mohammad Q. Hassan, Ronglin Xie, et al.. (2008). Co-stimulation of the Bone-related Runx2 P1 Promoter in Mesenchymal Cells by SP1 and ETS Transcription Factors at Polymorphic Purine-rich DNA Sequences (Y-repeats). Journal of Biological Chemistry. 284(5). 3125–3135. 67 indexed citations
10.
Young, Daniel, Mohammad Q. Hassan, Jitesh Pratap, et al.. (2007). Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2. Nature. 445(7126). 442–446. 191 indexed citations
11.
Mitra, Partha, Ronglin Xie, J. Wade Harper, et al.. (2006). HiNF‐P is a bifunctional regulator of cell cycle controlled histone H4 gene transcription. Journal of Cellular Biochemistry. 101(1). 181–191. 13 indexed citations
12.
Braastad, Corey, William F. Holmes, Partha Mitra, et al.. (2005). HiNF-P Directly Links the Cyclin E/CDK2/p220 NPAT Pathway to Histone H4 Gene Regulation at the G 1 /S Phase Cell Cycle Transition. Molecular and Cellular Biology. 25(14). 6140–6153. 86 indexed citations
13.
Xie, Ronglin, et al.. (2001). The Cell Cycle Control Element of Histone H4 Gene Transcription Is Maximally Responsive to Interferon Regulatory Factor Pairs IRF-1/IRF-3 and IRF-1/IRF-7. Journal of Biological Chemistry. 276(21). 18624–18632. 32 indexed citations
14.
Long, George L., Deshun Lu, Ronglin Xie, & Michael Kalafatis. (1998). Human Protein S Cleavage and Inactivation by Coagulation Factor Xa. Journal of Biological Chemistry. 273(19). 11521–11526. 33 indexed citations
15.
Lu, Deshun, Ronglin Xie, Andrzej Rydzewski, & George L. Long. (1997). The Effect of N-linked Glycosylation on Molecular Weight, Thrombin Cleavage, and Functional Activity of Human Protein S. Thrombosis and Haemostasis. 77(6). 1156–1163. 24 indexed citations
16.
Xie, Ronglin & George L. Long. (1996). Elements within the First 17 Amino Acids of Human Osteonectin Are Responsible for Binding to Type V Collagen. Journal of Biological Chemistry. 271(14). 8121–8125. 31 indexed citations
17.
Xie, Ronglin & George L. Long. (1995). Role of N-Linked Glycosylation in Human Osteonectin. Journal of Biological Chemistry. 270(39). 23212–23217. 27 indexed citations
18.
Kiliańska, Zofia M., et al.. (1991). Hepatoma‐associated nuclear matrix nonhistone antigens. Journal of Cellular Biochemistry. 45(3). 303–310. 3 indexed citations
19.
Fukuda, Kazunori, Ronglin Xie, & Jen‐Fu Chiu. (1991). Demonstration of cross-linked cytokeratin polypeptides in transplantable rat hepatoma cells. Biochemical and Biophysical Research Communications. 176(1). 441–446. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026